Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery

Circulation Journal

Volumn 74, Issue 9, 2010, Pages 1859-1865

  Komatsu, Takashi ^a   Tachibana, Hideaki ^a   Satoh, Yoshihiro ^a   Ozawa, Mahito ^a   Kunugita, Fusanori ^a   Tashiro, Atsushi ^a   Okabayashi, Hitoshi ^a   Nakamura, Motoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac surgery; Cibenzoline; Circadian rhythm; Disopyramide; Paroxysmal atrial fibrillation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIBENZOLINE; DISOPYRAMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CARDIOVASCULAR SURGERY; CARDIOVERSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VALVULAR HEART DISEASE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOVASCULAR SURGICAL PROCEDURES; DISOPYRAMIDE; FEMALE; HEART ATRIA; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956098197     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0023     Document Type: Article

References (40)

1. Mathew JP, Fontes ML, Tudor IC, Ramasay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-1729.
2. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, et al. Predictors of atrial fibrillation after coronary artery surgery: Current trends and impact on hospital resources. Circulation 1996; 94: 390-397.
3. Almassi GH, Schowwalter T, Nicolosi AC, Aggarwal A, Monritz TE, Henderson WG, et al. Atrial fibrillation after cardiac surgery: A major morbid event? Ann Surg 1997; 226: 501-511.
4. Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ, et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair. PAPABEAR: A randomized controlled trial. JAMA 2005; 294: 3093-3100.
5. Hravnak M, Hoffman LA, Saul MI, Zullo TG, Whitman GR, Griffith BP. Predictors and impact of atrial fibrillation after isolated coronary artery bypass grafting. Crit Care Med 2002; 30: 330-337.
6. Giri S, White CM, Dunn AB, Felton K, Freeman-Bosco L, Reddy P, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial (AFIST): A randomized placebo-controlled trial. Lancet 2001; 357: 830-836.
7. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Intervention on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: A meta-analysis. Circulation 2002; 106: 75-80.
8. Burgess DC, Kilborn MJ, Keech AC. Intervention for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: A meta-analysis. Eur Heart J 2006; 27: 2846-2857.
9. Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng CK, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: The pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebocontrolled trial. Am Heart J 2004; 147: 636-643.
10. Tsuboi J, Kawazoe K, Izumoto H, Okabayashi H. Postoperative treatment with carvedilol, a β-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. Circ J 2008; 72: 588-591.
11. Rossi M, Lown B. The use of quinidine in cardioversion. Am J Cardiol 1967; 19: 234-238.
12. Komatsu T, Tachibana H, Sato Y, Ozawa M, Ohshima K, Nakamura M, et al. A randomized study on the efficacy of intravenous cibenzoline and pilsicanide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation. J Cardiol 2009; 53: 35-42.
13. White CM, Caron MF, Kalus JS, Rose H, Song J, Reddy P, et al. Intravenous plus amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: The Atrial Fibrillation Suppression Trial II (AFIST-II). Circulation 2003; 108 (Suppl 1): II-200-II-206.
14. Komatsu T, Nakamura S, Suzuki O, Horiuchi D, Yomogida K, Okumura K. Long-term prognosis of patients with paroxysmal atrial fibrillation depends on their response to antiarrhythmic therapy. Circ J 2004; 68: 729-733.
15. Komatsu T, Tachibana H, Sato Y, Ozawa M, Kunugida F, Nakamura M, et al. Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation. Int Heart J 2009; 50: 465-476.
16. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH2009). Hypertens Res 2009; 32: 3-107.
17. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 2002 Guideline on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2007; 50: 1707-1732.
18. Dunning J, Treasure T, Versteegh M, Nashef SA; EACTS Audit and Guidelines Committee. Guideline on the prevention and management of the de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg 2006; 30: 852-872.
19. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery and Society of Thoracic Surgeons. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article. Circulation 2004; 110: 1168-1176.
20. Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51: 793-801.
21. Yamashita T, Murakawa Y, Sezaki K, Inoue M, Hayami N, Shuzui Y, et al. Circadian variation of paroxysmal atrial fibrillation. Circulation 1997; 96: 1537-1541.
22. Coumel P. Autonomic arrhythmogenic factors in paroxysmal atrial fibrillation. In: Olsson SB, Allesie MA, Campbell RWF, editors. Atrial fibrillation. Mechanisms and therapeutic strategies. Armonk: Futura Publishing, 1994; 171-185.
23. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American Collage/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: 700-752.
24. Gavaghan TP, Feneley MP, Campbell TJ, Morgan JJ. Atrial tachyarrhythmia after cardiac surgery: Results of disopyramide therapy. Aust N Z J Med 1985; 15: 27-32.
25. Campbell TJ, Morgan JJ. Treatment of atrial arrhythmia after car diac surgery with intravenous disopyramide. Aust N Z J Med 1980; 10: 644-649.
26. Campbell TJ, Gavaghan TP, Morgan JJ. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass: Comparison with disopyramide and digoxin in a randomized trial. Br Heart J 1988; 60: 497-501.
27. Gavaghan TP, Koegh AM, Kelly RP, Campbell TJ, Thorburn C, Morgan JJ. Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmia after cardiopulmonary bypass. Br Heart J 1988; 60: 497-501.
28. Toivonen LK, Nieminen MS, Manninen V, Frick MH. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol: A Placebo controlled study. Br Heart J 1986; 55: 176-180.
29. Capucci A, Lenzi T, Boriani G, Trisolino G, Binetti N, Cavazza M, et al. Effectiveness of loading oral flecainide for converting recentonset atrial fibrillation to sinus rhythm in patient without organic heart disease or with only systemic hypertension. Am J Cardiol 1992; 70: 69-72.
30. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit: A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991; 84: 1831-1851.
31. Fenster PE, Comess KA, Marsh R, Katzenberg C, Hager WD. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J 1983; 106: 501-504.
32. Halpen SW, Ellrodt G, Singh BN, Mandel WJ. Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm: Relation to left atrial size. Br Heart J 1980; 44: 589-595.
33. Camm J, Ward D, Spurrell RA. The effect of intravenous disopyramide phosphate on recurrent paroxysmal atrial tachycardia. Br J Clin Pharmacol 1979; 8: 441-449.
34. Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51: 793-801.
35. Song SW, Yi G, Lee S, Youn YN, Sul SY, Yoo KJ. Perioperative indicators of stress response and postoperative inflammatory complications in patients undergoing off-pump coronary artery bypass surgery: A prospective observational study. Circ J 2008; 72: 1966-1974.
36. Levy MN. Sympathetic-parasympathetic interaction in the heart. Circ Res 1971; 29: 437-445.
37. Dimmer C, Tavernier R, Gjorgov N, Van Nooten G, Clement DL, Jordaens L. Variation of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1998; 82: 22-25.
38. Vita JA, Friedman PL, Cantillon C, Antman EM. Efficacy of intravenous propafenone for the acute management of atrial fibrillation. Am J Cardiol 1989; 63: 1275-1281.
39. Toivonen LK, Nieminen MS, Manninen V, Frick MH. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol: A placebo controlled study. Br Heart J 1986; 55: 176-182.
40. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89: 224-227.